Barclays says shares of this mall operator could rebound 20% because of its high income customers
The firm said the stock is at an attractive entry point given the firm’s compelling growth and demographics.
This little-known biotech stock developing treatments for blood disorders could jump 80%, BMO says
The firm initiated coverage of this stock with an outperform rating and a $40 price target.
Ford’s EV business lost $2 billion in 2022, offset by big profits in fleet and legacy units
The financials are the first detailed look at EV profitability as Ford unveils a new financial reporting structure.
Oppenheimer downgrades Coinbase, cites ‘unhealthy regulatory climate’ after Wells notice
The firm said there are troubling signals for the digital asset sector following the collapse of Silicon Valley Bank and Signature Bank and other banks.
Cruise robotaxis blocked a road in San Francisco after a storm downed trees and wires
A witness told CNBC the driverless Cruise vehicles did not appear to detect and avoid the caution tape and bus wires, and instead became “tangled in them.”
FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease
FDA advisors voted against the effectiveness of Biogen’s investigational ALS drug, which could become the first to target a genetic cause of the disease.
Moderna CEO Stephane Bancel defends fivefold price hike of Covid vaccine during Senate grilling
Bernie Sanders pressed Stephane Bancel during the Senate hearing to make a commitment that Moderna will not increase the vaccine’s list price to $130.
Siding with Starbucks, House Republicans probe federal labor agency
A congressional committee has issued a subpoena for documents to the National Labor Relations Board, alleging its officials engaged in misconduct in union elections.
Here’s what the Federal Reserve’s 25 basis point interest rate hike means for your money
When the Federal Reserve changes its benchmark rate, everything from credit cards to savings accounts can be affected.
If you like big banks, there’s an ETF for that.
As regional banks continue to recover from the Silicon Valley Bank collapse, the ETF industry is rolling out a new product to address the turbulence.
